Literature DB >> 178421

Hydatidiform mole metastasizing to the lung.

P R Band, S R Masse, D W Reid, J B Dossetor.   

Abstract

Pulmonary lesions developed in three patients with an invasive hydatidiform mole. At open thoracotomy the modules were found to contain molar tissue. Therapy with twice-weekly methotrexate induced complete clinical and biologic remission of the disease in all three patients.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 178421      PMCID： PMC1957108     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


  8 in total

1.  Metastasizing benign trophoblastic tumors.

Authors:  R A THIELE; R R DE ALVAREZ
Journal:  Am J Obstet Gynecol       Date:  1962-12-01       Impact factor: 8.661

2.  Chorioadenoma destruens.

Authors:  R R GREENE
Journal:  Ann N Y Acad Sci       Date:  1959-08-28       Impact factor: 5.691

3.  Treatment of malignant trophoblastic growth in women, with special reference to amethopterin.

Authors:  M M HRESHCHYSHYN; J B GRAHAM; J F HOLLAND
Journal:  Am J Obstet Gynecol       Date:  1961-04       Impact factor: 8.661

4.  Follow-up after hydatidiform mole: studies using radioimmunoassay for urinary human chorionic gonadotrophin (HCG).

Authors:  K D Bagshawe; H Wilson; P Dublon; A Smith; M Baldwin; A Kardana
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-05

5.  The value of histological grading in the management of hydatidiform mole.

Authors:  C W Elston; K D Bagshawe
Journal:  J Obstet Gynaecol Br Commonw       Date:  1972-08

6.  The pathology of choriocarcinoma.

Authors:  W B Ober; J H Edgcomb; E B Price
Journal:  Ann N Y Acad Sci       Date:  1971-01-28       Impact factor: 5.691

7.  The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease.

Authors:  R L Shirley; D P Goldstein; J J Collins
Journal:  J Thorac Cardiovasc Surg       Date:  1972-04       Impact factor: 5.209

8.  Measurement of human luteinizing hormone in plasma by radioimmunoassay.

Authors:  D S Schalch; A F Parlow; R C Boon; S Reichlin
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.